ipriflavone has been researched along with Spinal Fractures in 5 studies
ipriflavone : A member of the class of isoflavones that is isoflavone in which the hydrogen at position 7 is replaced by an isopropoxy group. A synthetic isoflavone, it was formerly used for the treatment of osteoporosis, although a randomised controlled study failed to show any benefit. It is still used to prevent osteoporosis in post-menopausal women.
Spinal Fractures: Broken bones in the vertebral column.
| Excerpt | Relevance | Reference |
|---|---|---|
| " The incidence of adverse reactions in ipriflavone-treated patients (14." | 2.68 | Efficacy of ipriflavone in established osteoporosis and long-term safety. ( Agnusdei, D; Bufalino, L, 1997) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (60.00) | 18.2507 |
| 2000's | 2 (40.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Agnusdei, D | 1 |
| Bufalino, L | 3 |
| Reginster, JY | 2 |
| Christiansen, C | 2 |
| Devogelaer, JP | 2 |
| Gennari, C | 2 |
| Riis, BJ | 1 |
| Roux, C | 2 |
| Alexandersen, P | 1 |
| Toussaint, A | 1 |
| Fechtenbaum, J | 1 |
| Makita, K | 1 |
| Ohta, H | 1 |
| Passeri, M | 1 |
| Biondi, M | 1 |
| Costi, D | 1 |
| Castiglione, GN | 1 |
| Di Peppe, C | 1 |
| Abate, G | 1 |
1 review available for ipriflavone and Spinal Fractures
| Article | Year |
|---|---|
[Ipriflavone in the treatment of osteoporosis].
Topics: Animals; Bone Density; Bone Remodeling; Clinical Trials as Topic; Femoral Neck Fractures; Fractures, | 2002 |
4 trials available for ipriflavone and Spinal Fractures
| Article | Year |
|---|---|
Efficacy of ipriflavone in established osteoporosis and long-term safety.
Topics: Absorptiometry, Photon; Administration, Oral; Aged; Analysis of Variance; Bone Density; Bone Remodel | 1997 |
Design for an ipriflavone multicenter European fracture study.
Topics: Absorptiometry, Photon; Aged; Biomarkers; Bone Density; Bone Remodeling; Calcium; Double-Blind Metho | 1997 |
Ipriflavone in the treatment of postmenopausal osteoporosis: a randomized controlled trial.
Topics: Aged; Analysis of Variance; Biomarkers; Bone Density; Bone Remodeling; Double-Blind Method; Female; | 2001 |
Effect of ipriflavone on bone mass in elderly osteoporotic women.
Topics: Aged; Aged, 80 and over; Bone Density; Creatinine; Double-Blind Method; Female; Humans; Hydroxyproli | 1992 |